Gan W

ORCID: 0009-0009-5258-3061 · 4 papers in corpus
observational 2026
Journal of ovarian research ·doi:10.1186/s13048-026-02213-8

BACKGROUND: The 2023 International Federation of Gynecology and Obstetrics (FIGO) staging system introduced Stage IA3 to categorize a subset of synchronous endometrial and ovarian carcinomas (SEOC) with favorable outcomes. This study aims t…

review 2026
International journal of molecular medicine ·doi:10.3892/ijmm.2026.5996

Interleukin 37 (IL‑37), a member of the IL‑1 family, is recognized as an anti‑inflammatory cytokine. The anti‑inflammatory properties of recombinant human (rh)IL‑37 have been confirmed in vitro and its protective effects have been extensive…

review 2023
Frontiers in oncology ·doi:10.3389/fonc.2023.1291602

Synchronous endometrial and ovarian carcinoma (SEOC) is the most common combination of primary double cancer in the female reproductive system. The etiology and pathogenesis of SEOC remain unclear, and clinically, it is often misdiagnosed a…

other 2019
Nature genetics ·doi:10.1038/s41588-019-0447-2

An amendment to this paper has been published and can be accessed via a link at the top of the paper.